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Abstract— One of the main challenges for ultrasound
molecular imaging is acoustically distinguishing nonbound
microbubbles from those bound to their molecular target.
In this in vitro study, we compared two types of in-house
produced targeted lipid-coated microbubbles, either consisting of
1,2-dipalmitoyl-sn-glycero-3-phosphocholine, C16:0 (DPPC) or
1,2-distearoyl-sn-glycero-3-phosphocholine, C18:0 (DSPC) as the
main lipid, using the Brandaris 128 ultrahigh-speed camera to
determine vibrational response differences between bound and
nonbound biotinylated microbubbles. In contrast to previous
studies that studied vibrational differences upon binding, we
used a covalently bound model biomarker (i.e., streptavidin)
rather than physisorption, to ensure binding of the biomarker to
the membrane. The microbubbles were insonified at frequencies
between 1 and 4 MHz at pressures of 50 and 150 kPa. This
paper shows lower acoustic stability of bound microbubbles,
of which DPPC-based microbubbles deflated most. For DPPC
microbubbles with diameters between 2 and 4 µm driven at
50 kPa, resonance frequencies of bound microbubbles were all
higher than 1.8 MHz, whereas those of nonbound microbubbles
were significantly lower. In addition, the relative radial excursions
at resonance were also higher for bound DPPC microbubbles.
These differences did not persist when the pressure was increased
to 150 kPa, except for the acoustic stability which further
decreased. No differences in resonance frequencies were observed
between bound and nonbound DSPC microbubbles. Nonlinear
responses in terms of emissions at the subharmonic and second
harmonic frequencies were similar for bound and nonbound
microbubbles at both pressures. In conclusion, we identified
differences in vibrational responses of bound DPPC microbubbles
with diameters between 2 and 4 µm that distinguish them from
nonbound ones.
Index Terms— Biotin-streptavidin, lipid-coating, molecular
imaging, nonlinear behavior, targeted microbubbles, ultrahigh-
speed optical imaging, ultrasound contrast agents.
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I. INTRODUCTION
ULTRASOUND contrast agents that consist of targetedmicrobubbles are emerging in their applications for
ultrasound molecular imaging [1]–[3]. These microbubbles
have a ligand attached to their shell by which they can be
targeted to a specific biomarker, for example, αvβ3 that is
expressed on the cellular membrane of endothelial cells in
neovasculature [4], [5]. For successful translation of ultrasound
molecular imaging to the clinic, two major problems still need
to be tackled: 1) producing microbubbles of the same size that
also behave identical in an ultrasound field and 2) distinguish-
ing the response of a single targeted microbubble bound to
a specific biomarker from a nonbound targeted microbubble.
Since microbubbles of the same size can still have dif-
ferent acoustic properties [6]–[10], producing monodisperse
microbubbles may not necessarily result in microbubbles
that have, for example, the same resonance frequency. But
if it is possible to determine the acoustic parameters that
are specific for bound targeted microbubbles, they may be
distinguished from nonbound targeted microbubbles based on
their acoustic signal. Several studies investigated the difference
in acoustic properties of bound and nonbound microbubbles,
but these studies reported conflicting results. In the low-
frequency range (2–4 MHz) a shift in resonance frequency was
found for microbubbles after binding [11], [12], whereas at
11 and 25 MHz no shift was observed [13]. For the responses
at the subharmonic frequency either a change in frequency [13]
or no change in amplitude and frequency [14] was reported
upon binding. In contrast, for the response at the second
harmonic frequency, the results reported in [14] and [15]
were in agreement with each other: the amplitude increased
for bound microbubbles. Finally, Overvelde et al. [12] and
Zhao et al. [14] found a decrease in the vibrational response
at the fundamental frequency for bound microbubbles.
All acoustic studies on bound versus nonbound targeted
microbubbles used either physisorption as a method to attach
a model biomarker to an artificial surface (membrane or capil-
lary) [11], [12], [14], [15] or had the model biomarker embed-
ded in agarose [13]. Physisorption or physical adsorption relies
on electrostatic binding through van der Waals forces between
the biomarker and the membrane, but is in fact a very weak
bond [16], which can result in detachment of the biomarker
from the membrane or capillary. As a result, the biomarker
can cover the whole targeted microbubble, including the area
that is not directly in contact with the membrane. This was
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reported in [17] for the model biomarker streptavidin that was
physisorbed to an OptiCell membrane. Functionalization of
lipid-coated microbubbles with streptavidin changes the prop-
erties, such as elasticity [18]–[20] and acoustic stability [20].
Consequently, the comparisons made in previous studies
between bound microbubbles and nonbound microbubbles are
in fact a comparison between bound lipid-coated microbubbles
covered by streptavidin and nonbound lipid-coated microbub-
bles, which did not have streptavidin on their shell. In addition,
both physisorption and embedding a model biomarker in
agarose are far from the in vivo situation, where biomarkers
are incorporated into the cellular membrane.
We covalently linked a model biomarker to an artificial
surface to study the vibrational responses of single bound
targeted microbubbles and nonbound targeted microbubbles
aiming to find parameters to discriminate them acoustically.
Super-resolution confocal laser scanning fluorescence
microscopy showed that covalent coupling of the model
biomarker streptavidin to a hydrogel prevented the streptavidin
to bind to the biotinylated lipid-shell of the microbubble
outside the binding area [21]. That study compared the
lipid distribution and binding area of two types of targeted
lipid-coated microbubbles that were either coated with mainly
1,2-dipalmitoyl-sn-glycero-3-phosphocholine, C16:0 (DPPC)
which is the main shell component of Definity (Lantheus
Medical Imaging, North Billerica, MA, USA) or mainly
1,2-distearoyl-sn-glycero-3-phosphocholine, C18:0 (DSPC)
which is the main lipid component of SonoVue, Lumason, and
BR14 (Bracco Imaging S.p.A., Milan, Italy) [10], [21]–[25].
It was shown that the lipid distribution was more
homogeneous for DPPC-based microbubbles than for DSPC-
based microbubbles and that the binding area for DPPC-based
microbubbles was significantly larger than for DSPC-based
microbubbles [21]. We previously determined the acoustic
properties of these DPPC and DSPC-based microbubbles in a
setup where the microbubbles were floating against an Opti-
Cell wall (nonbound) [10] and hypothesized that the difference
in ligand distribution and binding area could alter the acoustic
response after adherence of the microbubble to its molecular
target. In this paper, we investigated the vibrational response
of in-house produced targeted DPPC-based and DSPC-based
microbubbles using the Brandaris 128 ultrahigh-speed optical
camera [26] when they had bound to a streptavidin-coated
hydrogel and compared their responses to those of nonbound
microbubbles floating against the hydrogel. We aimed to
identify differences in vibrational responses that may be used
to discriminate bound from nonbound microbubbles.
II. MATERIALS AND METHODS
A. Microbubble Preparation
Biotinylated lipid-coated microbubbles with a C4F10
gas core (F2 Chemicals Ltd, Preston, UK) were made
as previously described [21], [27] by sonication for
1 min. The coating was composed of 59.4 mol% DSPC
(P6517, Sigma-Aldrich, Zwijndrecht, The Netherlands) or
DPPC (850355, Avanti Polar Lipids, Alabaster, AL, USA),
35.7 mol% polyoxyethylene-40-stearate (PEG-40 stearate,
P3440, Sigma-Aldrich), 4.1 mol% 1,2-distearoyl-sn-glycero-3-
phosphoethanolamine-N-[carboxy(polyethylene glycol)-2000]
(DSPE-PEG(2000), 880125, Avanti Polar Lipids); and
0.8 mol% 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-
N-[biotinyl(polyethylene glycol)-2000] [DSPE-PEG(2000)-
biotin, 880129, Avanti Polar Lipids].
A 25-μm-thick polyester membrane was mounted on a
custom-made rectangular polyvinylchloride holder (same size
as a microscope objective glass) and was custom-coated with a
1–2-μm-thick polycarboxylate hydrogel (XanTec bioanalytics
GmbH, Düsseldorf, Germany). For the bound targeted
microbubbles, the hydrogel was activated and strepta-
vidin (S4762, Sigma-Aldrich) was subsequently covalently
attached to the hydrogel, using the amine coupling kit
(K AN-50, XanTec bioanalytics GmbH) according to the
instructions of the manufacturer, as previously described [21].
Briefly, streptavidin was dissolved in acetate buffer (2 mM,
pH 5.4) (1 mg/mL). After desalting the streptavidin by use
of a PD-10 desalting column (GE Healthcare Bio-Sciences),
the concentration was determined spectrophotometrically at
570 nm using a Pierce BCA Protein Assay kit (Thermo
Scientific) and Thermo Multiskan EX. Three polyester mem-
branes were placed in a 5-Slidemailer (Heathrow Scientific,
Northgate, U.K.) with 18 mL of 1 M NaCl + 0.1 M NaB
(pH 10) elution buffer (K AN-50, XanTec bioanalytics
GmbH), followed by an incubation with 18 mL of 1.6% (w/v)
EDC · HCL (K AN-50, XanTec bioanalytics GmbH) in
activation NHS/MES buffer (K AN-50, XanTec bioanalytics
GmbH), and 18 mL of 33 μg/mL desalted streptavidin
in 2 mM acetate buffer at pH 5.2–5.4. Finally, 18 mL
of 1 M ethanolamine hydrochloride (pH 8.5) quenching
buffer (K AN-50, XanTec bioanalytics GmbH) was used
to terminate the reaction. The targeted microbubbles were
allowed to adhere to the streptavidin-coated membrane in
air-equilibrated phosphate buffered saline (PBS) containing
calcium and magnesium (DPBS, 14080, Invitrogen, Thermo
Fischer Scientific, Landsmeer, The Netherlands) by flotation
for 5 min. Then, the membrane was gently washed three times
with air-equilibrated PBS containing calcium and magnesium
using a 3 mL plastic Pasteur pipette. For the nonbound targeted
microbubbles the hydrogel was treated in the same way, except
for the addition of streptavidin. The targeted microbubbles
were added below the hydrogel-coated polyester membrane of
the custom-made holder and floated up due to buoyancy. The
hydrogels with the nonbound targeted microbubbles and bound
targeted microbubbles were orientated in the setup as shown
in Fig. 1.
B. Microbubble Spectroscopy
The vibrational responses of the bound and
nonbound targeted microbubbles were captured using
the Brandaris 128 ultrahigh-speed camera operated at
∼15 million frames/s [26]. Single microbubbles were
investigated in Region Of Interest (ROI) mode [28] using
the microbubble spectroscopy technique [6] in combination
with the exact same setup as in [10], except for a higher
magnification microscope objective (60×, NA = 0.9,
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Fig. 1. Configuration and composition of nonbound targeted microbub-
bles (top) floating against a hydrogel and targeted microbubbles bound to this
hydrogel via streptavidin (bottom) in the experimental setup (not to scale).
Olympus, Tokyo, Japan). Briefly, a broadband single element
polyvinyl difluoride (PVDF) transducer (25-mm focal
distance, f-number 1.1, center frequency 5 MHz, PA275,
Precision Acoustics Ltd, Dorchester, UK) transmitted a
Gaussian tapered eight-cycle sine wave burst at transmit
frequencies swept from 1 to 4 MHz (increment steps
of 200 kHz) at a peak-negative pressure (PA) of 50 or
150 kPa at the focus. The pressures were calibrated with
two calibrated PVDF needle hydrophones in a separate
measurement beforehand (0.2-mm diameter PA2030 and
1-mm diameter PA1875, Precision Acoustics). The optic
focus was aligned with the acoustic focus, to ensure that the
microbubble received the intended pressure. The ultrasound
was triggered on the second recording of each microbubble
to obtain the initial resting diameter and the noise level with
our contour tracking algorithm in the first recording. The
experiments were conducted at room temperature and the
sample was submersed in air-equilibrated PBS containing
calcium and magnesium. All microbubbles were exposed
to ultrasound within 2 h after addition to the custom-made
holder.
C. Data Analysis
Diameter-time (D-t) curves were obtained using custom-
designed image analysis software [6] that determines the
vibrational responses as described elsewhere [10]. Briefly,
the acoustic stability of the microbubbles was quantified as
the difference between the mean diameter of the microbubble
in the initial D-t curve (D0) and the final D-t curve (Dend).
Next, the asymmetry of the D-t curves was measured as
the ratio E/C between the relative expansion E , defined as
(Dmax–D0)/D0, and the relative compression C , defined
as (D0–Dmin)/D0, of the microbubble. Where Dmax is the
maximum diameter, Dmin the minimum diameter in the
D-t curve, and D0 the resting diameter before vibration.
The E/C ratios were used to classify the asymmetry as:
1) compression-only behavior (E/C < 0.5); 2) normal
excursion (0.5 ≤ E/C ≤ 2); or 3) expansion-only behavior
(E/C > 2) [29].
Using the fast Fourier transformation (FFT) the frequency
content of the D-t curves was analyzed in terms of the
amplitude at the transmit frequency ( fT ). These amplitudes
were fit to a resonance curve of a linear oscillator by a least-
mean-squares method [6], [10] to determine the resonance
frequency ( fres) of the microbubble. Fres was usually located
in between two insonifications. The microbubble diameters at
these insonifications are known, and the diameter at resonance
Dres was determined from an interpolation between these
two insonifications. The maximum relative radial excursions
(i.e., at fres) were defined as the maximum amplitude of the
FFT divided by the corresponding resting diameter of the
microbubble [10]. The same approach was used to determine
the subharmonic resonance frequencies ( fsub) and the sec-
ond harmonic resonance frequencies, and the corresponding
maximum relative radial excursions. Next, the maximum
relative radial excursions were transformed into pressures
using [9], [10]
PS = −ρω
2
res R2resε
d
(1)
where PS is the scattered pressure at a distance d from
the microbubble, ρ = 1 · 103 kg/m3 is the density of the
surrounding fluid (PBS), ωres = 2π fres the angular resonance
frequency, Rres the corresponding radius, and ε is the maxi-
mum relative radial excursion amplitude. All calculations were
performed in MATLAB (The MathWorks Inc., Natick, MA,
USA).
D. Statistics
Shapiro–Wilk tests for normality showed that the data was
not normally distributed, so we used nonparametric testing. For
comparing the acoustic stability of the microbubbles we used
Wilcoxon signed-rank tests. When comparing groups, e.g.,
bound DSPC and nonbound DSPC, we used Mann-Whitney
U tests. Medians and interquartile ranges (IQRs) are reported
and were calculated using Tukey’s Hinges method. Statistical
analyses were performed using SPSS (Statistics 21, IBM
Corporation, Armonk, NY, USA) and a p-value <0.05 was
regarded as significant.
III. RESULTS
In total, 143 single microbubbles having a D0 between
1.5 and 10 μm were analyzed. At 50 kPa, 46 bound DPPC
microbubbles were insonified; 18 of which were also insoni-
fied at 150 kPa. For bound DSPC microbubbles, 43 were
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Fig. 2. Still frames of the Brandaris ultrahigh-speed recordings of a bound DPPC-based microbubble insonified at pressures of 50 and 150 kPa
(see Supplemental Material for the movies). The initial state is indicated with “no US” and D0 is determined from this recording. At a frequency of 1 MHz,
two frames have been selected: one in the expansion phase and one in the compression phase of the oscillation, as also indicated by the black dots in the
D-t curves. The curve at a pressure of 150 kPa shows inertial cavitation and thus asymmetric behavior. Acoustic deflation is clearly visible when comparing
Dend, determined from the 4-MHz recordings, with D0.
insonified at 50 kPa; 15 of which were also insonified at
150 kPa. None of the bound microbubbles detached during
the experiments since every microbubble remained within
the optic focus. For the nonbound microbubbles we included
26 DPPC and 28 DSPC microbubbles, which were all insoni-
fied at both 50 and 150 kPa.
A. Acoustic Stability
Fig. 2 shows an example of a bound DPPC-based microbub-
ble insonified at a pressure of 50 kPa and subsequently
at 150 kPa. Comparing D0 with Dend at both pressures shows
a clear decrease in diameter. The corresponding ultrahigh-
speed Brandaris recordings can be found in the Supplementary
Material, as well those of a bound DSPC-based microbubble.
Overall, at PA = 50 kPa, both bound DPPC and DSPC-
based microbubbles deflated significantly more than when
they were nonbound ( p = 0.0001), as shown in Fig. 3.
The median size for the bound DPPC microbubbles after
insonification was 83% of D0, while this was 98% for the non-
bound DPPC microbubbles. The median size of bound DSPC
microbubbles was 93% of D0 after insonification, whereas
nonbound DSPC microbubbles maintained their original size
(100% of D0). At a pressure of 150 kPa, the size difference
between bound DPPC and nonbound DPPC microbubbles
was not significant. The median diameter after insonification
decreased to 53% of D0 for bound DPPC microbubbles and
to 56% for nonbound DPPC microbubbles. In case of DSPC
microbubbles, those that had bound deflated more than those
that had not ( p = 0.004). For the DSPC microbubbles this
was 76% for the bound ones and hardly any shrinkage (98%
of their initial size) for the nonbound ones. In addition, for
both bound and nonbound microbubbles, those based on DPPC
deflated more than those based on DSPC at 50 kPa (bound:
p = 0.001, nonbound: p = 0.031) and also at 150 kPa
(both p = 0.0001).
B. Linear Oscillation Behavior
The resonance frequencies in relation to Dres are shown in
Fig. 4. First of all, at a pressure of 50 kPa the resonance
frequencies of bound DSPC microbubbles were similar to
those of nonbound DSPC microbubbles. For DPPC-based
microbubbles, the resonance frequencies of bound microbub-
bles were significantly higher than for nonbound DPPC
microbubbles (p = 0.045). To further highlight the differences
in resonance frequencies between bound and nonbound DPPC
microbubbles, we compared the resonance frequencies of those
having Dres < 4 μm. For larger microbubbles all reso-
nance frequencies were similar, but for microbubbles having
a Dres < 4 μm, the resonance frequencies of bound DPPC
microbubbles were significantly higher than for nonbound
DPPC microbubbles (p = 0.002). In addition, no overlap was
found between the median (IQR) resonance frequencies of
bound DPPC microbubbles and nonbound DPPC microbub-
bles (Table I). In contrast, the resonance frequencies of bound
and nonbound DSPC microbubbles were similar for all studied
sizes (p = 0.494). The resonance frequencies of bound DSPC
microbubbles were significantly higher than those of bound
DPPC-based microbubbles at PA = 50 kPa (p = 0.001), for
the nonbound DSPC and DPPC microbubbles no difference
was found. All resonance frequencies at a pressure of 150 kPa
were similar. The number of microbubbles included in Figs.
4 and 5 is lower than the total number of studied microbub-
bles, since some resonance peaks were below or above the
measuring range (<1 or >4 MHz); the resonance frequency
could therefore not be determined.
For bound DPPC microbubbles, the maximum relative radial
excursions at a pressure of 50 kPa were significantly higher
than for the nonbound DPPC microbubbles ( p = 0.002, Fig. 5,
Table I). Although the maximum relative radial excursions
of bound DSPC microbubbles were not significantly different
from nonbound DSPC microbubbles (p = 0.157) over the
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Fig. 3. Diameter change during ultrasound exposure expressed as D0/Dend
for bound DPPC (50 kPa: n = 46, 150 kPa: n = 18), nonbound DPPC (50 kPa:
n = 28, 150 kPa: n = 28), bound DSPC (50 kPa: n = 43, 150 kPa: n = 15),
and nonbound DSPC microbubbles (50 kPa: n = 26, 150 kPa: n = 26). The
filled black circles are outliers.
whole resonance frequency range, the maximum relative radial
excursions for bound DSPC microbubbles were significantly
higher for resonance frequencies >2 MHz (p = 0.001).
In addition, the maximum relative radial excursions of bound
DSPC microbubbles were significantly lower than of bound
DPPC microbubbles (p = 0.0001), but similar for the non-
bound DSPC and DPPC microbubbles. At a driving pres-
sure of 150 kPa the maximum relative radial excursions
of bound and nonbound DPPC microbubbles were similar,
but significantly higher for bound DSPC than nonbound
DSPC microbubbles (p = 0.001). The maximum relative
radial excursions for bound DPPC and bound DSPC-based
microbubbles were similar (Fig. 5, Table I). For nonbound
Fig. 4. Resonance frequencies ( fres) of bound DPPC (filled red circles),
nonbound DPPC (red crosses), bound DSPC (blue open circles), and non-
bound DSPC (blue crosses) microbubbles plotted versus the diameter at reso-
nance (Dres) at PA = 50 kPa (top panel) and PA = 150 kPa (bottom panel).
microbubbles the maximum relative radial excursions were
significantly higher (p = 0.03) for DPPC microbubbles than
for DSPC microbubbles.
C. Nonlinear Oscillation Behavior
The asymmetry of the radial excursions at each transmit
frequency was expressed as the ratio between the relative
expansion E and relative compression C . At 50 kPa, the
median of the radial excursions was compression-dominated
with 0.5 < E/C < 1 for bound targeted microbubbles
of both types (Fig. 6) at all frequencies. For the nonbound
microbubbles the oscillations were mostly symmetric, except
for the frequencies between 1 and 1.6 MHz for which the
radial excursions of DPPC microbubbles were compression-
dominated. At PA = 150 kPa the excursion behavior of
bound microbubbles at frequencies between 1 and 1.8 MHz
ranged from symmetric to expansion-dominated, whereas at
higher frequencies the behavior of both microbubble types was
compression-dominated. An example of a bound DPPC-based
microbubble showing asymmetric oscillations at 150 kPa due
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TABLE I
RESONANCE FREQUENCIES AND MAXIMUM RELATIVE RADIAL
EXCURSIONS PROVIDED AS MEDIAN (IQR)
to inertial cavitation is shown in Fig. 2. The nonbound
microbubbles showed mostly symmetric oscillations.
Responses at the subharmonic frequency at a driving
pressure of 50 kPa were present in 22 out of 46 (48%)
bound DPPC microbubbles and in 7 out of 43 (16%) bound
DSPC microbubbles. For both nonbound DPPC and DSPC
microbubbles only one (4%) responded at the subharmonic
frequency. At the higher pressure of 150 kPa, the number
of bound DPPC microbubbles responsive at the subharmonic
frequency was similar to that at 50 kPa: 8 out of 18 (44%), but
increased to 9 out of 15 (60%) for DSPC-based microbubbles.
The number of nonbound microbubbles that responded at the
subharmonic frequency increased to 12 out of 28 (43%) for
DPPC and 6 out of 26 (23%) for DSPC microbubbles.
For quite some microbubbles a response at the subhar-
monic frequency was observed in the FFT of the D-t curves.
However, to determine the scattered subharmonic pressures
using (1), the subharmonic resonance frequency fsub is
required; fsub could only be determined for the microbubbles
shown in Fig. 7. Reasons for not being able to determine the
subharmonic resonance curve were not enough points for a
fit or the peak of the subharmonic resonance curve was below
or above the measuring range. Emitted subharmonic pressures
at a distance of 2 cm were similar irrespective of binding and
the type of lipid coating at each acoustic pressure (Fig. 7), but
their origin was different. At 50 kPa, of the 17 bound DPPC
microbubbles shown in Fig. 7, nine had a response at transmit
at twice the resonance frequency (T2R with fsub = fres
[30], [31]) and four at transmit at the resonance frequency
(TR, fsub = 1/2 fres [8], [30]). Of the seven bound DSPC
microbubbles, three had a clear response at T2R and none
Fig. 5. Maximum relative radial excursions at the resonance frequency
of bound DPPC (filled red circles) nonbound DPPC (red crosses), bound
DSPC (blue open circles), and nonbound DSPC (blue crosses) microbubbles
plotted versus the resonance frequency ( fres) at PA = 50 kPa (top panel) and
PA = 150 kPa (bottom panel).
had a response at TR. At 150 kPa, of the eight bound DPPC
microbubbles seven had a response at T2R and one at TR.
Of the seven bound DSPC microbubbles four had a response
at T2R and none at TR. In the case of nonbound microbubbles
at 50 kPa the only microbubble responsive at fsub was a
DSPC microbubble with a response at T2R. At 150 kPa, one
out of the ten DPPC microbubbles had a response at T2R
and two out of ten at TR. For the four nonbound DSPC
microbubbles two had a response at T2R and none at TR.
For the other microbubbles responding at fsub, the relation
between TR or T2R could not be determined; either because
no clear relation was found between the subharmonic and
fundamental frequency, or because the fundamental frequency
had not been determined since the peak was located outside the
measuring range. We assumed a detection limit of 1 Pa (black
dashed line in Fig. 7) for diagnostic ultrasound scanners,
achievable with a typical high-quality transducer for harmonic
imaging [32].
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Fig. 6. Median (IQR) ratio between the relative expansion E and the relative compression C of bound DPPC (50 kPa: n = 37, 150 kPa: n = 18) and bound
DSPC (50 kPa: n = 43, 150 kPa: n = 15) microbubbles (top panels), and nonbound DPPC (50 kPa: n = 28, 150 kPa: n = 28) and nonbound DSPC (50 kPa:
n = 26, 150 kPa: n = 26) microbubbles (bottom panels) plotted versus the transmit frequency at PA = 50 kPa (left panels) and PA = 150 kPa (right panels).
Fig. 7. Absolute pressures emitted at the subharmonic resonance frequency
of bound DPPC (50 kPa: n = 17, 150 kPa: n = 8), bound DSPC
microbubbles (50 kPa: n = 7, 150 kPa: n = 7), nonbound DPPC (50 kPa:
n = 0, 150 kPa: n = 10), and nonbound DSPC microbubbles (50 kPa: n = 1,
150 kPa: n = 4).
At PA = 50 kPa, about half of both bound DPPC (53%)
and bound DSPC (57%) microbubbles responded at the second
harmonic frequency. The number of responding nonbound
microbubbles based on DPPC was similar (50%), but for
nonbound DSPC microbubbles only 1 out of 26 (4%) was
responsive at the second harmonic frequency. The number
of responsive microbubbles at a driving pressure of 150 kPa
increased in all cases: to 14 out of 15 (93%) for bound
DPPC, 13 out of 18 (72%) for bound DSPC, 17 out of
28 (61%) for nonbound DPPC, and 8 out of 26 (31%) for
nonbound DSPC microbubbles. The median (IQR) pressures
emitted at the second harmonic frequency when insonified at
50 kPa were 2.0 (1.0–2.6) Pa for bound DSPC microbub-
bles, hence in the same order as the only nonbound DSPC
microbubble (3.1 Pa, Fig. 8). For bound and nonbound DPPC
microbubbles, the emitted pressures were not significantly
different (p = 0.351). In addition, the emitted pressures at
the second harmonic frequency of bound DPPC microbub-
Fig. 8. Absolute pressures emitted at the second harmonic resonance
frequency of bound DPPC (50 kPa: n = 21, 150 kPa: n = 10), bound DSPC
microbubbles (50 kPa: n = 19, 150 kPa: n = 8), nonbound DPPC (50 kPa:
n = 6, 150 kPa: n = 6), and nonbound DSPC microbubbles (50 kPa: n = 1,
150 kPa: n = 4).
bles were higher than those of bound DSPC microbubbles
(p = 0.004). At the higher driving pressure of 150 kPa,
the emitted pressures were significantly higher (p = 0.017)
for nonbound than bound DSPC microbubbles, with median
pressures of 28.5 (14.0–38.1) Pa for nonbound and
3.2 (2.4–8.4) Pa for bound DSPC microbubbles. The median
pressures of the other groups were all similar.
IV. DISCUSSION
This paper investigated vibrational responses of bound and
nonbound microbubbles to identify differences to acousti-
cally discriminate them. For DPPC-based microbubbles with
diameters between 2 and 4 μm the resonance frequencies
and relative radial excursions were higher than for nonbound
DPPC-based microbubbles (PA = 50 kPa). In contrast, at an
insonifying pressure of 150 kPa the relative radial excursions
for bound and nonbound DPPC-based microbubbles were sim-
ilar. Interestingly, at this higher pressure the radial excursions
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for bound DSPC-based microbubbles were higher than for
nonbound DSPC microbubbles, whereas these were similar
at 50 kPa. We also found compression-dominated behavior
and a higher number of responsive microbubbles at the second
harmonic frequency for bound microbubbles, irrespective of
the main coating lipid.
A. Acoustic Stability
Bound microbubbles were acoustically less stable than
nonbound microbubbles, irrespective of their main coating
component. Further, we found that the acoustic stability for
DPPC-based microbubbles was lower than that for DSPC-
based microbubbles. This was previously attributed to the
shorter acyl chain length of the DPPC lipid than that of the
DSPC lipid [10]. This shorter chain results in lower inter-
molecular van der Waals forces between the different lipids
and results in less attraction and cohesion of the microbubble
shell [10], [33]. The maximum relative radial excursions of
bound microbubbles were higher at the resonance frequency
than those of nonbound microbubbles (for DPPC at 50 kPa
and DSPC at 150 kPa). This means that the radial excursions
after binding were more prominent, which resulted in more
shrinkage and therefore a lower acoustic stability. Others have
reported lower radial excursions after binding for DSPC-
based microbubbles [12], [14], but those studies had not
covalently linked their model biomarker to their membrane.
As a result, the biomarker that attached to the microbubble
shell increased the stiffness [20] and therefore limits the radial
oscillations.
Some nonbound DSPC microbubbles appeared to increase
in diameter after insonification at 150 kPa. The microbub-
bles in which this was observed were all relatively
small (<2.5 μm). This apparent increase may be due to
small changes in the optic focus due to radiation forces,
in combination with the error in the tracking algorithm which
was previously estimated to be approximately 10% [6].
B. Linear Oscillation Behavior
The resonance frequencies for bound DPPC microbubbles
were higher than for nonbound DPPC microbubbles at a
pressure of 50 kPa for microbubbles with diameters between
2 and 4 μm at resonance. Based on the IQRs, the resonance
frequencies of most bound DPPC microbubbles of this size
were higher than 1.8 MHz, whereas those of nonbound DPPC
microbubbles were lower than 1.8 MHz. In terms of shell
properties, a higher resonance frequency is related to an
increase in elasticity (i.e., a stiffer shell) by the Marmottant
model [34]. It is not likely that the elasticity changes upon
binding, but the apparent stiffness may increase due to binding
of the microbubble to the biomarker. We may not have found
a change in apparent stiffness for DSPC-based microbubbles,
because their surface binding area is smaller than for DPPC-
based microbubbles as previously determined by our group
for the same type of microbubbles and same streptavidin bio-
marker [21]. Next, the initial elasticity of DSPC microbubbles
is already higher than for DPPC microbubbles [10], and it
has been shown that the resonance frequencies for DSPC
microbubbles did not change after conjugating the relatively
heavy molecule streptavidin to the lipid shell, whereas for
DPPC microbubbles the resonance frequencies increased [20].
In addition, the resonance frequency exponentially decreases
for increasing microbubble size [35]. As a consequence,
the difference in resonance frequencies for microbubbles with
diameters between 2 and 4 μm is larger than for microbubbles
with diameters between 5 and 7 μm [10]. An increase in
resonance frequency for bound microbubbles will therefore
be more pronounced for smaller than for larger microbubbles.
This may explain why the apparent increase in stiffness was
only present for bound DPPC microbubbles having diameters
between 2 and 4, and not for DSPC microbubbles or larger
DPPC microbubbles. At 150 kPa, however, all resonance
frequencies appeared the same. The microbubble oscillations
at this pressure start off very violently (i.e., inertial cavi-
tation) in the first insonifications between 1 and 1.5 MHz,
thereby largely decreasing the microbubble size and shifting its
original resonance frequency toward higher frequencies. Since
the mechanical index was ∼2× lower for the insonifications
at the end of the frequency sweep, the resulting relative
radial excursions were lower at the new resonant microbubble
size. Therefore, the oscillations of the first insonifications
dominated the resonance behavior, leading to an apparent
resonance frequency between 1 and 1.5 MHz before shrinkage.
Others have also reported differences in resonance
frequencies between bound and nonbound microbubbles.
Casey et al. [15] reported an increase in resonance frequency
for their bound in-house produced biotinylated microbubbles,
but for DSPC microbubbles (C3F8 gas core and same compo-
nents as our DSPC-based microbubbles, but unknown ratios)
instead of for DPPC-based microbubbles as we report here.
Overvelde et al. [12] found 30% lower frequencies of maxi-
mum response for targeted BG-6438 microbubbles bound to
an OptiCell wall than for nontargeted BG-6437 microbubbles
floating against the wall at pressures <40 kPa (both bubble
types are from Bracco Research S.A., Geneva, Switzerland).
The BG-6438 microbubbles were targeted to FITC-BSA using
an anti-FITC antibody attached to the microbubble shell
using streptavidin-biotin bridging. The main limitation of
both studies is the method of attaching the model biomarker
streptavidin to the cellulose tube [15] or FITC-BSA to the
OptiCell wall [12], namely, by physisorption. As mentioned
before, this physisorbed biomarker is likely to bind to the
microbubble shell creating a lipid-coated microbubble cov-
ered with the model biomarker. These very large and heavy
complexes are expected to behave completely different in an
ultrasound field than a bare lipid-coated targeted microbub-
ble, as has been shown for microbubbles that were func-
tionalized with streptavidin, depending on the initial stiff-
ness of the microbubble coating [20]. In addition to this,
Overvelde et al. [12] did not block the OptiCells to prevent
unspecific binding in their experiments that compared free
BG-6437 microbubbles and BG-6437 microbubbles close to
the wall: the latter may have actually bound to the wall.
Next to that, the BG-6437 microbubbles did not have anti-
FITC antibody attached to their shell, which is not a fair
comparison between microbubbles that have bound to the wall
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and that are floating against the wall. In our present study,
the covalent coupling of streptavidin to the hydrogel, and thus
the membrane, was established and it was confirmed that no
streptavidin was present on the microbubble shell [21].
C. Nonlinear Oscillation Behavior
For nonlinear contrast-enhanced ultrasound imaging the
responses at the subharmonic and second harmonic frequen-
cies are usually exploited [36]. At 50 kPa more bound
than nonbound microbubbles responded at the subharmonic
frequency, for both the DPPC and DSPC-based coatings.
At 150 kPa more microbubbles—both bound and nonbound—
were responsive at the subharmonic frequency, but the emitted
pressures of single microbubbles were close to or below the
assumed detection limit for clinical use of 1 Pa [32]. Based on
these results, the subharmonic emissions seem of limited use
for nonlinear contrast-enhanced imaging and discrimination of
bound from nonbound microbubble based on our experimental
conditions. However, when multiple microbubbles are in close
proximity of each other, their subharmonic emissions could
be in phase and the resulting cumulative pressure may be
higher [13]. This is worth to further investigate, but was
outside the scope of this paper.
We found similar amplitudes at the subharmonic frequency
for bound and nonbound microbubbles, in line with the
findings of Zhao et al. [14] for microbubbles with a coating
of 82 mol% DSPC, 9 mol% DSPE-PEG(2000), and 9 mol%
DSPE-PEG(2000)-biotin [37]. Helfield et al. [13] reported
similar amounts of bound and nonbound Target-Ready Micro-
Marker microbubbles that were responsive at the subharmonic
frequency, whereas we found more bound microbubbles that
responded. The different composition and gas core of Target-
Ready MicroMarker likely contributed to these differences.
As suggested in [13], the membrane material could have
frequency-dependent effects and their results might be biased
due to aggregation of microbubbles that may have changed the
echogenicity [38]. We previously performed the exact same
experiments as described here for nonbound microbubbles in
an OptiCell [39]. Indeed, a membrane dependent effect was
observed, but was not found to be frequency related. The
maximum relative radial excursions of nonbound microbubbles
in an OptiCell (both DPPC and DSPC) were 2–2.5 times
higher than for nonbound microbubbles floating against the
hydrogel. Because the microbubbles may be partly embedded
in the polymer-based hydrogel, this can damp the microbubble
oscillations and therefore result in lower maximum relative
radial excursions.
Another difference between our study and that in [13] is
that they coated their cellulose tube with streptavidin using
physisorption, with the disadvantage of streptavidin covering
the microbubble shell, which may have influenced the ampli-
tude of the subharmonic signal. Indeed, their acoustic mea-
surements showed a 20% higher subharmonic signal of Target-
Ready MicroMarker, a streptavidin-functionalized lipid-coated
microbubble, when bound to a biotinylated agarose phantom.
The difference between the results in [13] and our results pre-
sented in this paper might also be due to the used techniques:
ultrahigh-speed optical imaging versus acoustic measurements.
In our setup, we were only able to image the top-view of
the microbubble oscillations, whereas acoustic measurements
can detect out-of-plane signals as well. If a larger portion
of the subharmonic excursions were generated in the perpen-
dicular plane, we might have missed those vibrations with
our setup.
Numerical simulations have shown that the subharmonic
signal is optimal when the microbubble is insonified at
T2R [40]. Experimental validation showed that the threshold
for generating TR subharmonic responses is higher than that
for T2R subharmonic responses in lipid-coated microbubbles
[30], [41]. The absence of DSPC responders at TR may
suggest that the threshold for generating TR subharmonic
responses is lower for DPPC microbubbles than for DSPC
microbubbles, irrespective of them being bound or not. On the
other hand, due to the applied frequency range and studied
microbubble sizes, the majority of the resonance frequencies
were between 1.5 and 3.5 MHz; this limits the possibility to
insonify microbubbles at T2R within the frequency range we
applied.
The higher second harmonic amplitudes we measured for
nonbound DSPC-based microbubbles at 150 kPa are in con-
trast with results reported by others [11], [15]. The study
in [15] used microbubbles similar to our DSPC microbubbles,
but with a C3F8 core and attachment to a capillary wall using
the physisorbed streptavidin as biomarker ( fT = 2 MHz,
PA = 90 kPa). The study in [11] also used DSPC-based
microbubbles, with a setup and parameters comparable to
those in [15]. Both studies used somewhat lower pressures, but
may also have effectively studied bound targeted DSPC-based
microbubbles coated with a streptavidin layer, which may
explain the different findings. In our study, the emitted pressure
amplitudes of bound microbubbles were similar or lower than
for nonbound microbubbles and acoustic discrimination based
on the second harmonic pressures does therefore not seem
feasible.
D. DSPC Versus DPPC for Ultrasound Molecular
Imaging Applications
The differences between bound targeted DPPC and
DSPC-based microbubbles were not as pronounced as we
expected from the differences in shape change upon adherence
and their surface binding areas, as previously determined by
our group for the same type of microbubbles and same strepta-
vidin biomarker [21]. The most prominent differences we did
find were higher acoustic stability for nonbound microbubbles,
higher resonance frequencies (for DPPC microbubbles with
diameters between 2 and 4 μm) and radial excursions for
bound DPPC microbubbles at 50 kPa, and higher ampli-
tudes at the second harmonic frequency for nonbound DSPC
microbubbles than for bound DSPC microbubbles at 150 kPa.
The lower resonance frequencies for DPPC microbubbles than
for DSPC microbubbles were already observed for nonbound
DPPC microbubbles [10], and were thus maintained upon
binding.
For in vivo ultrasound molecular imaging the ideal targeted
microbubble: 1) can effectively bind to the biomarker of
interest; 2) persists binding to the biomarker after initial
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binding, i.e., the binding strength is larger than the shear
stress induced by the flowing blood; 3) is stable during the
course of the ultrasound examination; 4) nonlinearly scatters
ultrasound that is microbubble specific; 5) can be discrimi-
nated acoustically from nonbound microbubbles; and 6) has
the same resonance frequency as the other microbubbles that
are injected, i.e., all microbubbles in the population respond in
the same way to ultrasound. Concerning the first two points,
Kooiman et al. [21] favored targeted DPPC microbubbles
over DSPC microbubbles because of their larger surface
binding area to a streptavidin-coated membrane, their dome
shape after binding, and a more homogeneous distribution of
fluorescently labeled ligands attached to DSPE-PEG(2000).
The more homogeneous lipid distribution might aid the initial
attachment, whereas the larger binding area and difference
in shape might be able to better sustain blood shear forces.
However, binding of the microbubbles was performed under
static conditions and experiments in the presence of flow are
required to verify which of the two microbubble types binds
best under flow. Based on the acoustic stability (point 3),
DSPC-based microbubbles are favored over DPPC-based
microbubbles. This also means that the size is better main-
tained during insonification and the resonance frequency will
therefore be more consistent throughout the investigation.
In terms of nonlinear scattering of ultrasound (point 4),
the maximum relative radial excursions at the subharmonic
frequency for both our DPPC and DSPC microbubbles resulted
in ∼20 dB lower scattered pressures than the second harmonic
responses. The subharmonic responses were unpredictable and
too low to discriminate bound from nonbound microbubbles.
In contrast, the responses at the second harmonic frequency
were sufficiently high to be detected, but amplitudes were
similar for bound and nonbound microbubbles, or higher
for the nonbound ones in terms of DSPC-based microbub-
bles (point 5). At 50 kPa, bound and nonbound DPPC
microbubbles with diameters between 2 and 4 μm at resonance
could be separated based on their resonance frequencies:
bound DPPC microbubbles had resonance frequencies above
1.8 MHz, whereas those were significantly lower for non-
bound DPPC microbubbles. Lastly (point 6), as mentioned
in the introduction one of the main challenges for successful
translation of ultrasound molecular imaging to the clinic is
the production of microbubble populations that have the same
acoustic signature. Both the DPPC and DSPC-based microbub-
bles can have different resonance frequencies and radial
excursions although their sizes are similar. Several studies
showed that monodisperse lipid-coated microbubble distribu-
tions can be produced using flow-focusing devices [42]–[45].
Kaya et al. [43] and Talu et al. [45] studied the differ-
ence between echo amplitudes of these monodisperse sin-
gle microbubbles when insonified at a frequency close to
resonance, and found a lower standard deviation than for
polydisperse microbubbles. Segers and Versluis [46] devel-
oped an acoustic sorting chip that separated monodisperse
microbubbles based on the radiation force they experienced,
which resulted in an overall contrast enrichment of more
than 10 dB. This is an important step toward improving the
quality of in vivo ultrasound molecular imaging, especially if
microbubbles with low shell elasticity and a diameter between
2 and 4 μm can be produced to distinguish bound from
nonbound microbubbles, as shown in our study. However, this
approach is still limited to specific microbubble compositions
that can be produced monodispersely by means of flow-
focusing devices.
Summing up all the aforementioned similarities, differences,
advantages, and disadvantages of DPPC and DSPC-based
microbubbles, this results in a favor for DSPC-based
microbubbles for ultrasound molecular imaging, solely based
on a higher acoustic stability. Studying the adherence of
the microbubbles under flow should reveal whether the
heterogeneous lipid distribution in the DSPC shell hinders
binding. On the other hand, bound DPPC microbubbles
(diameters between 2 and 4 μm) at 50 kPa had resonance
frequencies higher than 1.8 MHz, whereas those of nonbound
DPPC microbubbles were lower than 1.8 MHz. In addition,
the relative radial excursions of bound DPPC microbubbles
were also higher. When monodisperse DPPC microbubbles
with a diameter between 2 and 4 μm are produced, these
could acoustically be discriminated based on their resonance
frequency.
E. Limitations and Outlook
Although we aimed to create a more in vivo-like setup using
covalent biomarker binding versus physisorption, the mem-
brane we used in our experiments was still artificial. The
1–2-μm-thick hydrogel created a softer layer between the
microbubble and the polyester membrane, but to have a real
in vivo-like membrane one would need to develop a material
with exactly the same stiffness, viscosity, etc. as an actual cell
layer or perform in vivo experiments. In addition, in vivo one
can also study microbubble vibration when microbubbles are
in contact with cells and under flow, for which the chorioallan-
toic membrane model could be used. This model has proven
to be useful to study nontargeted microbubble vibration using
ultrahigh-speed imaging and targeted-microbubble mediated
drug delivery [47], [48].
For in vivo ultrasound molecular imaging multiple
microbubbles may bind in closer range with each other than
investigated in this paper. However, the binding range actually
depends on the availability of the biomarker on the cell
surface, which depends both on the cell type and the biomarker
of interest. When the interbubble distance is ≤10 μm, this will
cause interaction of the bubbles in terms of secondary Bjerknes
forces, and due to the secondary Bjerknes forces a bubble
will deform in the direction of their neighboring bubble [49].
Next to that, two similar sized bubbles that are close to each
other result in a shift in resonance frequency and therefore a
decrease in maximum relative radial excursions [50]. As a con-
sequence, for abundant biomarkers on the cell membrane these
observations may counteract the increase in resonance fre-
quency and maximum relative radial excursions we observed
for DPPC microbubbles between 2 and 4 μm at 50 kPa. This,
however, should first be experimentally verified using a setup
comprising of a biomarker distribution that is comparable to
the in vivo situation. The chorioallantoic model would be a
good approach to study this.
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V. CONCLUSION
This paper shows that binding of in-house produced
DPPC-based microbubbles to a streptavidin-coated surface
increased the resonance frequencies (for microbubbles with
diameters between 2 and 4 μm) and the corresponding rel-
ative radial excursions at relatively low pressure (50 kPa).
At this pressure, the bound 2- to 4-μm microbubbles resonated
above 1.8 MHz, whereas the nonbound 2- to 4-μm DPPC
microbubbles were resonant below this frequency. In terms of
nonlinear responses, only the responses at the second harmonic
frequency of bound DSPC microbubbles at 150 kPa were
lower than of nonbound DSPC microbubbles. Our in-house
produced DSPC-based microbubbles were acoustically more
stable than our DPPC-based microbubbles, which is the major
advantage of this type of microbubble for ultrasound molecular
imaging applications.
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